185 related articles for article (PubMed ID: 12365891)
1. Quality-of-life assessment after supradose selective intra-arterial cisplatin and concomitant radiation (RADPLAT) for inoperable stage IV head and neck squamous cell carcinoma.
Ackerstaff AH; Tan IB; Rasch CR; Balm AJ; Keus RB; Schornagel JH; Hilgers FJ
Arch Otolaryngol Head Neck Surg; 2002 Oct; 128(10):1185-90. PubMed ID: 12365891
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience.
Robbins KT; Kumar P; Regine WF; Wong FS; Weir AB; Flick P; Kun LE; Palmer R; Murry T; Fontanesi J; Ferguson R; Thomas R; Hartsell W; Paig CU; Salazar G; Norfleet L; Hanchett CB; Harrington V; Niell HB
Int J Radiat Oncol Biol Phys; 1997 May; 38(2):263-71. PubMed ID: 9226312
[TBL] [Abstract][Full Text] [Related]
3. Treatment of advanced head and neck cancer with intra-arterial cisplatin and concurrent radiation therapy: the 'RADPLAT' protocol.
Kumar P; Robbins KT
Curr Oncol Rep; 2001 Jan; 3(1):59-65. PubMed ID: 11123871
[TBL] [Abstract][Full Text] [Related]
4. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615.
Robbins KT; Kumar P; Harris J; McCulloch T; Cmelak A; Sofferman R; Levine P; Weisman R; Wilson W; Weymuller E; Fu K
J Clin Oncol; 2005 Mar; 23(7):1447-54. PubMed ID: 15735120
[TBL] [Abstract][Full Text] [Related]
5. First-year quality of life assessment of an intra-arterial (RADPLAT) versus intravenous chemoradiation phase III trial.
Ackerstaff AH; Balm AJ; Rasch CR; de Boer JP; Wiggenraad R; Rietveld DH; Gregor RT; Kröger R; Hilgers FJ
Head Neck; 2009 Jan; 31(1):77-84. PubMed ID: 18972429
[TBL] [Abstract][Full Text] [Related]
6. The superselective intra-arterial infusion of cisplatin and concomitant radiotherapy (RADPLAT) is effective for metastatic lymph nodes in head and neck squamous cell carcinoma.
Kano S; Suzuki T; Yoshida D; Tsushima N; Hamada S; Yasuda K; Uchinami Y; Aoyama H; Homma A
Int J Clin Oncol; 2023 Sep; 28(9):1121-1128. PubMed ID: 37289379
[TBL] [Abstract][Full Text] [Related]
7. High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer.
Balm AJ; Rasch CR; Schornagel JH; Hilgers FJ; Keus RB; Schultze-Kool L; Ackerstaff AH; Busschers W; Tan IB
Head Neck; 2004 Jun; 26(6):485-93. PubMed ID: 15162349
[TBL] [Abstract][Full Text] [Related]
8. Intra-arterial chemotherapy less intensive than RADPLAT with concurrent radiotherapy for resectable advanced head and neck squamous cell carcinoma: a prospective study.
Yoshizaki T; Wakisaka N; Murono S; Kondo S; Shimizu Y; Takanaka T; Sanada J; Terayama N; Matsui O; Furukawa M
Ann Otol Rhinol Laryngol; 2007 Oct; 116(10):754-61. PubMed ID: 17987781
[TBL] [Abstract][Full Text] [Related]
9. Treatment outcomes of locally advanced squamous cell carcinoma of the maxillary sinus treated with chemoradioselection using superselective intra-arterial cisplatin and concomitant radiation: Implications for prognostic factors.
Ono T; Tanaka N; Umeno H; Chitose SI; Shin B; Aso T; On K; Hattori C; Etoh H; Kakuma T; Abe T
J Craniomaxillofac Surg; 2017 Dec; 45(12):2128-2134. PubMed ID: 29122485
[TBL] [Abstract][Full Text] [Related]
10. High-dose cisplatin concurrent to conventionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma.
de Castro G; Snitcovsky IM; Gebrim EM; Leitão GM; Nadalin W; Ferraz AR; Federico MH
Eur Arch Otorhinolaryngol; 2007 Dec; 264(12):1475-82. PubMed ID: 17643256
[TBL] [Abstract][Full Text] [Related]
11. Bone or cartilage invasion by advanced head and neck cancer: intra-arterial supradose cisplatin chemotherapy and concomitant radiotherapy for organ preservation.
Samant S; Robbins KT; Kumar P; Ma JZ; Vieira F; Hanchett C
Arch Otolaryngol Head Neck Surg; 2001 Dec; 127(12):1451-6. PubMed ID: 11735813
[TBL] [Abstract][Full Text] [Related]
12. Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: disease control and preservation of organ function.
Samant S; Kumar P; Wan J; Hanchett C; Vieira F; Murry T; Wong FS; Robbins KT
Head Neck; 1999 Oct; 21(7):595-601. PubMed ID: 10487945
[TBL] [Abstract][Full Text] [Related]
13. Factors predictive of local disease control after intra-arterial concomitant chemoradiation (RADPLAT).
Robbins KT; Doweck I; Samant S; Vieira F; Kumar P
Laryngoscope; 2004 Mar; 114(3):411-7. PubMed ID: 15091211
[TBL] [Abstract][Full Text] [Related]
14. High-dose intra-arterial cisplatin boost with hyperfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck.
Regine WF; Valentino J; Arnold SM; Haydon RC; Sloan D; Kenady D; Strottmann J; Pulmano C; Mohiuddin M
J Clin Oncol; 2001 Jul; 19(14):3333-9. PubMed ID: 11454880
[TBL] [Abstract][Full Text] [Related]
15. Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Recchia F; Saggio G; Cesta A; Amiconi G; di Blasio A; Candeloro G; Valeriani M; Tombolini V; Rea S
Anticancer Res; 2006; 26(3B):2317-24. PubMed ID: 16821609
[TBL] [Abstract][Full Text] [Related]
16. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.
Wanebo HJ; Glicksman AS; Landman C; Slotman G; Doolittle C; Clark J; Koness RJ
Am J Surg; 1995 Nov; 170(5):512-6. PubMed ID: 7485745
[TBL] [Abstract][Full Text] [Related]
17. A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer.
Robbins KT; Vicario D; Seagren S; Weisman R; Pellitteri P; Kerber C; Orloff L; Los G; Howell SB
Am J Surg; 1994 Nov; 168(5):419-22. PubMed ID: 7977964
[TBL] [Abstract][Full Text] [Related]
18. Five-year quality of life results of the randomized clinical phase III (RADPLAT) trial, comparing concomitant intra-arterial versus intravenous chemoradiotherapy in locally advanced head and neck cancer.
Ackerstaff AH; Rasch CR; Balm AJ; de Boer JP; Wiggenraad R; Rietveld DH; Gregor RT; Kröger R; Hauptmann M; Vincent A; Hilgers FJ
Head Neck; 2012 Jul; 34(7):974-80. PubMed ID: 21818820
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of high-dose intraarterial cisplatin chemotherapy with concomitant accelerated radiotherapy for patients with previously untreated T4 and selected patients with T3N0-N3M0 squamous cell carcinoma of the upper aerodigestive tract.
Foote RL; Kasperbauer JL; Okuno SH; Nichols DA; Olsen KD; Brown PD; Garces YI; Sargent DJ; Strome SE
Cancer; 2005 Feb; 103(3):559-68. PubMed ID: 15597408
[TBL] [Abstract][Full Text] [Related]
20. Swallowing and speech ability after treatment for head and neck cancer with targeted intraarterial versus intravenous chemoradiation.
Newman LA; Robbins KT; Logemann JA; Rademaker AW; Lazarus CL; Hamner A; Tusant S; Huang CF
Head Neck; 2002 Jan; 24(1):68-77. PubMed ID: 11774405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]